CASP3 and Miyoshi myopathy: Moreover, investigations into multiple myeloma (MM) have confirmed that a therapeutic approach combining SFN with arsenic trioxide (ATO) synergistically enhances the anti-neoplastic efficacy of ATO against MM by inducing PARP cleavage and increasing caspase-3 and -4 expression [102].